In 1992, Congress created what’s commonly known as the 340B program in order to help safety-net hospitals and clinics stretch limited resources to serve low-income and uninsured patients. By requiring ...

When the first set of prices under the Medicare Drug Price Negotiation Program went into effect, they intersected with the 340B Drug Pricing Program and created the potential for billions of dollars ...

The Health Resources and Services Administration (HRSA) announced that it is moving forward with a revised 340B rebate pilot that would allow qualifying drug manufacturers to provide post-purchase ...

The 340B Drug Pricing Program, meant for low-income patients to get cheaper medications, is being exploited. Its loopholes must be closed.

The 340B Drug Pricing Program is under growing scrutiny, and maintaining the status quo is unrealistic. However, the new ASCO policy position 1 to increase participation in 340B is not reform.

“The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual relationships, and compliance programs if these reforms advance,” Daphne Kackloudis, ...

A proposed rule issued last month by the Centers for Medicare & Medicaid Services (CMS) would affect Medicare payment rates for both ...

Treatment Tolerability in Older Adults With Advanced Cancer Receiving Geriatric Assessment–Guided Versus Oncologist-Guided Primary Treatment Modification: Secondary Analysis of the GAP70+ Trial The ...

The 340B Drug Pricing Program may be partly driving U.S. hospital consolidation and worsening affordability for patients, some analysts have warned.